Pattern to Present in London, UK at the LSX World Congress
April 16 2024 - 7:02PM
Pattern Computer®, Inc. (“Pattern” or “the Company”) today
announced that Mark R. Anderson, Chairman and CEO, will be
presenting at the LSX World Congress which will take place in
London, UK on April 29-30, 2024, at the Business Design Center.
Pattern will be announcing new drug patent filings and test results
addressing the world’s top five cancers, and exciting new test
results for its real-time screening device, ProSpectral™.
LSX World Congress is the leading partnering, strategy, and
investment event in Europe, with a strong focus on one-to-one
partnering. The event brings together the CEOs and senior decision
makers from the world’s most innovative biopharma, medtech and
healthtech companies with investors, senior BD&L teams, R&D
leaders, and industry KOLs. Together, they share best practices,
and forge partnerships and investments – all geared to putting
capital and ideas to work to help create the world’s future
medicines and improve patient outcomes.
For additional information on Pattern or to meet with the
Company during the conference, please contact Pattern’s Executive
Vice President of Special Projects, Denyse Hudson, at
denyse@patterncomputer.com.
“Pattern is a pioneer in finding novel patterns in complex data
that cannot be discovered using other techniques or tools,”
commented Mr. Anderson. “The speed of AI innovation is accelerating
and is rapidly emerging as a strategic imperative. Pattern is
optimally positioned to leverage the expertise of our Pattern
Discovery Engine™ (PDE) into the next worlds of trustworthy,
transparent computing. Since its founding, Pattern has been on a
strategic path with a roadmap largely focused on building our PDE
and using it to generate high-value assets, which we are now at an
inflection point to commercialize. These assets include and are not
limited to: combination cancer drug discoveries and diagnostic
advances against the world’s top five cancers, in which we are
looking to partner with firms to bring these drugs into clinical
trials; the Pattern Discovery Engine™; ProSpectral™, a
game-changing medical diagnostic tool and research instrument; and
TrueXAI™.” Mr. Anderson concluded, “These products have already led
to major new pattern discoveries in the most competitive and
important fields of endeavor. With continued innovation and
collaboration, we can create a better future for everyone.”
About PatternPattern Computer, Inc. uses its
Pattern Discovery Engine™ to solve the most important and
intractable problems in business and medicine. These proprietary
mathematical techniques in advanced AI can find complex patterns in
very-high-order data that have eluded detection by much larger
systems. As the Company applies its computational platform to the
challenging fields of drug discovery and diagnostics, it is also
making major Pattern Discoveries for partners in other sectors,
including extended biotech, materials science, aerospace
manufacturing quality control, veterinary medicine, air traffic
operations, and energy services. See www.patterncomputer.com.
CONTACT: Laura Guerrant-Oiye (808)
960-2642 – laura@patterncomputer.com
The foregoing contains statements about Pattern Computer’s
future that are not statements of historical fact. These statements
are “forward looking statements” for purposes of applicable
securities laws and are based on current information and/or
management’s good faith belief as to future events. The words
“believe,” “expect,” “anticipate,” “project,” “should,” “could,”
“will,” and similar expressions signify forward-looking statements.
Forward-looking statements should not be read as a guarantee of
future performance. By their nature, forward-looking statements
involve inherent risk and uncertainties, which change over time,
and actual performance could differ materially from that
anticipated by any forward-looking statements. Pattern Computer
undertakes no obligation to update or revise any forward-looking
statement.
Copyright © 2024 Pattern Computer Inc. All Rights Reserved.
Pattern Computer, Inc., Pattern Discovery Engine, PatternBio,
TrueXAI, and ProSpectral are trademarks of Pattern Computer Inc. or
its subsidiaries. Other trademarks may be trademarks of their
respective owners.